As of 2025-05-25, the Relative Valuation of Inhibrx Inc (INBX) is 2,299.80 USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.86 USD, the upside of Inhibrx Inc based on Relative Valuation is 17783.3%.
The range of the Relative Valuation is 1,715.50 - 2,713.17 USD.
| Range | Selected | |
| Trailing P/E multiples | 19.1x - 23.3x | 22.4x |
| Forward P/E multiples | 19.3x - 25.1x | 22.4x |
| Fair Price | 1,715.50 - 2,713.17 | 2,299.80 |
| Upside | 13239.8% - 20997.7% | 17783.3% |
| Date | P/E |
| 2025-05-23 | 0.11 |
| 2025-05-22 | 0.11 |
| 2025-05-21 | 0.11 |
| 2025-05-20 | 0.11 |
| 2025-05-19 | 0.11 |
| 2025-05-16 | 0.11 |
| 2025-05-15 | 0.10 |
| 2025-05-14 | 0.09 |
| 2025-05-13 | 0.10 |
| 2025-05-12 | 0.10 |
| 2025-05-09 | 0.10 |
| 2025-05-08 | 0.10 |
| 2025-05-07 | 0.10 |
| 2025-05-06 | 0.11 |
| 2025-05-05 | 0.11 |
| 2025-05-02 | 0.10 |
| 2025-05-01 | 0.11 |
| 2025-04-30 | 0.11 |
| 2025-04-29 | 0.10 |
| 2025-04-28 | 0.11 |
| 2025-04-25 | 0.11 |
| 2025-04-24 | 0.10 |
| 2025-04-23 | 0.10 |
| 2025-04-22 | 0.10 |
| 2025-04-21 | 0.10 |
| 2025-04-17 | 0.10 |
| 2025-04-16 | 0.10 |
| 2025-04-15 | 0.10 |
| 2025-04-14 | 0.10 |
| 2025-04-11 | 0.10 |
| 2025-04-10 | 0.10 |
| 2025-04-09 | 0.11 |
| 2025-04-08 | 0.10 |
| 2025-04-07 | 0.10 |
| 2025-04-04 | 0.11 |
| 2025-04-03 | 0.11 |
| 2025-04-02 | 0.12 |
| 2025-04-01 | 0.12 |
| 2025-03-31 | 0.12 |
| 2025-03-28 | 0.12 |
| 2025-03-27 | 0.12 |
| 2025-03-26 | 0.12 |
| 2025-03-25 | 0.12 |
| 2025-03-24 | 0.13 |
| 2025-03-21 | 0.12 |
| 2025-03-20 | 0.12 |
| 2025-03-19 | 0.12 |
| 2025-03-18 | 0.12 |
| 2025-03-17 | 0.12 |
| 2025-03-14 | 0.12 |